EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Homologous recombination deficiency ( HRD ) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma

Xinyi Zhou, Haoxuan Ying, Yujie Sun, Wenda Zhang, Peng Luo, Shuhan Zhu, Jian Zhang

The Journal of Pathology: Clinical Research · 2024

DOI: 10.1002/2056-4538.12391 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Pathology: Clinical Research, 2024. Verfasst von Xinyi Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, PR China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, BRCA1 Protein. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province, National Natural Science Foundation of China, Guangzhou Municipal Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homologous recombination deficiency (HRD) score is a reliable indicator of genomic instability. The significance of HRD in nasopharyngeal carcinoma (NPC), particularly its influence on prognosis and the immune microenvironment, has yet to be adequately explored. Understanding HRD status comprehensively can offer valuable insights for guiding precision treatment. We utilised three cohorts to investigate HRD status in NPC: the Zhujiang cohort from local collection and the Hong Kong ( SRA288429 ) and Singapore ( SRP035573 ) cohorts from public datasets. The GATK (genome analysis toolkit) best practice process was employed to investigate germline and somatic BRCA1/2 mutations and various bioinformatics tools and algorithms to examine the association between HRD status and clinical molecular characteristics. We found that individuals with a negative HRD status (no‐HRD) exhibited a higher risk of recurrence [hazard ratio (HR), 1.43; 95% confidence interval (CI), 2.03–333.76; p = 0.012] in the Zhujiang cohort, whereas, in the Singapore cohort, they experienced a higher risk of mortality (HR, 26.04; 95% CI, 1.43–34.21; p = 0.016) compared with those in the HRD group. In vitro experiments demonstrated that NPC cells with BRCA1 knockdown exhibit heightened sensitivity to chemoradiotherapy. Furthermore, the HRD group showed significantly higher tumour mutational burden and tumour neoantigen burden levels than the no‐HRD group. Immune infiltration analysis indicated that HRD tissues tend to have a non‐inflamed tumour microenvironment. In conclusion, patients with HRD exhibit a comparatively favourable prognosis in NPC, possibly associated with a non‐inflammatory immune microenvironment. These findings have positive implications for treatment stratification, enabling the selection of more precise and effective therapeutic approaches and aiding in the prediction of treatment response and prognosis to a certain extent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentNasopharyngeal CarcinomaNasopharyngeal NeoplasmsBRCA1 ProteinHumansMaleFemalePrognosisMiddle AgedBRCA2 ProteinMutationAdultHomologous RecombinationBiomarkers, TumorNeoplasm Recurrence, LocalGenomic Instability

Stichwörter der Autor:innen

homologous recombination deficiency scorenasopharyngeal carcinomanon‐inflamed tumour microenvironmentplatinum compounds and PARP inhibitorsprecision treatmentprognostic valuesensitivity to chemoradiotherapysi‐BRCA1

Substanzen

BRCA1 ProteinBRCA1 protein, humanBRCA2 ProteinBRCA2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, PR China.

Förderung

  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National Natural Science Foundation of China
  • Guangzhou Municipal Science and Technology Project
  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Zhou, X., Ying, H., Sun, Y., Zhang, W., Luo, P., Zhu, S., & Zhang, J. (2024). Homologous recombination deficiency ( HRD ) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma. The Journal of Pathology: Clinical Research. https://doi.org/10.1002/2056-4538.12391

Vancouver

Zhou X, Ying H, Sun Y, Zhang W, Luo P, Zhu S, et al. Homologous recombination deficiency ( HRD ) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma. The Journal of Pathology: Clinical Research. 2024. doi:10.1002/2056-4538.12391

BibTeX
@article{Zhou2024,
  author = {Zhou, Xinyi and Ying, Haoxuan and Sun, Yujie and Zhang, Wenda and Luo, Peng and Zhu, Shuhan and Zhang, Jian},
  title = {Homologous recombination deficiency ( HRD ) is associated with better prognosis and possibly causes a non‐inflamed tumour microenvironment in nasopharyngeal carcinoma},
  journal = {The Journal of Pathology: Clinical Research},
  year = {2024},
  doi = {10.1002/2056-4538.12391}
}
Kostenlos starten →